| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |